PhotoCure and GE Healthcare introduce Hexvix in Europe
Oslo, Norway, April 7, 2006. PhotoCure together with GE Healthcare, their licensing partner for Hexvix, initiated the introduction of Hexvix in Europe at the 21st EAU annual meeting in Paris April 5-7. PhotoCure and GE Healthcare held a combined exhibit and also co-hosted a satellite symposium dedicated to Hexvix. This is the largest meeting in Europe for urologists arranged by the European Association of Urologists (EAU) with approximately 10.000 delegates. Hexvix is approved in Europe for the diagnosis of bladder cancer, and GE Healthcare are in the process of transferring the